ARCHIVES

DCT Board Approves New Task Orders For RMP Clinical Trials, Holds Up On Additional Grants

This article is from The Cancer Letter archive.

Vol. 07 No. 08 | February 20, 1981

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Adds Georgetown, MSK to Program

May 1, 1981

NIH COI Rule Mandates More Disclosure, Leaves Institutions In Charge Of Ethics Of Extramural Researchers

September 16, 2011

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

September 26, 2008

Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months

September 27, 2013

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013